Advertisement Synteract names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Synteract names new CEO

US based contract research organization (CRO) Synteract has named Wendel Barr as the new CEO with immediate effect.

Most recently, Barr worked as the chief operating officer and executive vice president of Covance.

Before Covance, he worked with Marconi Medical Systems as the vice president and general manager.

Barr said he is pleased to join Synteract at this point in its growth phase.

Synteract offers clinical trial services to biotechnology, medical device, and pharmaceutical companies.